1887

Abstract

is a major swine pathogen and an emerging zoonotic agent. The ability of pathogenic bacteria to bind the complement regulator factor H on their cell surface may allow them to avoid complement attack and phagocytosis. The aim of this study was to characterize a new cell surface protein possessing factor H-binding activity in serotype 2. The capacity of to bind the complement regulator factor H on its surface was demonstrated by ELISA. Using a factor I–cofactor assay, it was found that the functional activity of factor H bound to was kept. Since the product of gene in P1/7 shared similarity with a protein (named PspC) possessing factor H-binding activity, it was proposed as a putative factor H receptor in has a 1686 bp open reading frame encoding a 561 amino acid protein containing the Gram-positive cell wall anchoring motif (LPXTG) at the carboxy-terminal, an amino-terminal signal sequence, an α-helix domain, a proline-rich region and a G5 domain. The gene was cloned in and the purified recombinant factor H-binding protein showed a molecular mass of 95 kDa, as determined by SDS-PAGE. The protein possessed the functional property of binding factor H. Sera from -infected pigs reacted with the recombinant factor H receptor, suggesting that it is produced during the course of infections. In conclusion, we identified a novel cell surface protein that binds the complement factor H. This cell surface protein may help to resist complement attack and phagocytosis and contribute to pathogenesis.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.057877-0
2013-07-01
2020-09-30
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/7/1073.html?itemId=/content/journal/jmm/10.1099/jmm.0.057877-0&mimeType=html&fmt=ahah

References

  1. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. 1997 Current Protocols in Molecular Biology New York, NY: Greene Publishing and Wiley Interscience;
    [Google Scholar]
  2. Balachandran P., Brooks-Walter A., Virolainen-Julkunen A., Hollingshead S. K., Briles D. E. 2002; Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. . Infect Immun 70:2526–2534 [CrossRef][PubMed]
    [Google Scholar]
  3. Bonifait L., Vaillancourt K., Gottschalk M., Frenette M., Grenier D. 2011; Purification and characterization of the subtilisin-like protease of Streptococcus suis that contributes to its virulence. Vet Microbiol 148:333–340 [CrossRef][PubMed]
    [Google Scholar]
  4. Esgleas M., Dominguez-Punaro M. de L., Li Y., Harel J., Dubreuil J. D., Gottschalk M. 2009; Immunization with SsEno fails to protect mice against challenge with Streptococcus suis serotype 2. FEMS Microbiol Lett 294:82–88 [CrossRef][PubMed]
    [Google Scholar]
  5. Fittipaldi N., Segura M., Grenier D., Gottschalk M. 2012; Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. . Future Microbiol 7:259–279 [CrossRef][PubMed]
    [Google Scholar]
  6. Geng H., Zhu L., Yuan Y., Zhang W., Li W., Wang J., Zheng Y., Wei K., Cao W. et al. 2008; Identification and characterization of novel immunogenic proteins of Streptococcus suis serotype 2. J Proteome Res 7:4132–4142 [CrossRef][PubMed]
    [Google Scholar]
  7. Giuliani M. M., Adu-Bobie J., Comanducci M., Aricò B., Savino S., Santini L., Brunelli B., Bambini S., Biolchi A. et al. 2006; A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A 103:10834–10839 [CrossRef][PubMed]
    [Google Scholar]
  8. Gottschalk M., Xu J., Lecours M. P., Grenier D., Fittipaldi N., Segura M. 2010; Streptococcus suis infections in humans: what is the prognosis for Western countries? (Part I). Clin Microbiol Newsl 32:89–96 [CrossRef]
    [Google Scholar]
  9. Iannelli F., Oggioni M. R., Pozzi G. 2002; Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. . Gene 284:63–71 [CrossRef][PubMed]
    [Google Scholar]
  10. Iannelli F., Chiavolini D., Ricci S., Oggioni M. R., Pozzi G. 2004; Pneumococcal surface protein C contributes to sepsis caused by Streptococcus pneumoniae in mice. Infect Immun 72:3077–3080 [CrossRef][PubMed]
    [Google Scholar]
  11. Jarva H., Jokiranta T. S., Würzner R., Meri S. 2003; Complement resistance mechanisms of streptococci. Mol Immunol 40:95–107 [CrossRef][PubMed]
    [Google Scholar]
  12. Li W., Liu L., Qiu D., Chen H., Zhou R. 2010; Identification of Streptococcus suis serotype 2 genes preferentially expressed in the natural host. Int J Med Microbiol 300:482–488 [CrossRef][PubMed]
    [Google Scholar]
  13. Lu L., Ma Y., Zhang J.-R. 2006; Streptococcus pneumoniae recruits complement factor H through the amino terminus of CbpA. J Biol Chem 281:15464–15474 [CrossRef][PubMed]
    [Google Scholar]
  14. McDowell J. V., Wolfgang J., Senty L., Sundy C. M., Noto M. J., Marconi R. T. 2004; Demonstration of the involvement of outer surface protein E coiled coil structural domains and higher order structural elements in the binding of infection-induced antibody and the complement-regulatory protein, factor H. J Immunol 173:7471–7480[PubMed] [CrossRef]
    [Google Scholar]
  15. Nilsson E., Ekdahl K. N. 1998; Component of the alternative pathway. In The Complement System, pp. 23–49 Edited by Rother K., Till G. O., Hänsch. G. M. Berlin: Springer;
    [Google Scholar]
  16. Okwumabua O., Persaud J. S., Reddy P. G. 2001; Cloning and characterization of the gene encoding the glutamate dehydrogenase of Streptococcus suis serotype 2. Clin Diagn Lab Immunol 8:251–257[PubMed]
    [Google Scholar]
  17. Oliver M. A., Rojo J. M., Rodríguez de Córdoba S., Alberti S. 2008; Binding of complement regulatory proteins to group A Streptococcus. . Vaccine 26:Suppl 8I75–I78 [CrossRef][PubMed]
    [Google Scholar]
  18. Pian Y., Gan S., Wang S., Guo J., Wang P., Zheng Y., Cai X., Jiang Y., Yuan Y. 2012; Fhb, a novel factor H-binding surface protein, contributes to the antiphagocytic ability and virulence of Streptococcus suis. Infect Immun 80:2402–2413 [CrossRef][PubMed]
    [Google Scholar]
  19. Rodríguez de Córdoba S., Esparza-Gordillo J., Goicoechea de Jorge E., Lopez-Trascasa M., Sánchez-Corral P. 2004; The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41:355–367 [CrossRef][PubMed]
    [Google Scholar]
  20. Ruggiero A., Tizzano B., Pedone E., Pedone C., Wilmanns M., Berisio R. 2009; Crystal structure of the resuscitation-promoting factor (DeltaDUF)RpfB from M. tuberculosis. J Mol Biol 385:153–162 [CrossRef][PubMed]
    [Google Scholar]
  21. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press;
    [Google Scholar]
  22. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74:5463–5467 [CrossRef][PubMed]
    [Google Scholar]
  23. Shao Z., Pan X., Li X., Liu W., Han M., Wang C., Wang J., Zheng F., Cao M., Tang J. 2011; HtpS, a novel immunogenic cell surface-exposed protein of Streptococcus suis, confers protection in mice. FEMS Microbiol Lett 314:174–182 [CrossRef][PubMed]
    [Google Scholar]
  24. Staats J. J., Feder I., Okwumabua O., Chengappa M. M. 1997; Streptococcus suis: past and present. Vet Res Commun 21:381–407 [CrossRef][PubMed]
    [Google Scholar]
  25. Zipfel P. F., Skerka C. 2009; Complement regulators and inhibitory proteins. Nat Rev Immunol 9:729–740[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.057877-0
Loading
/content/journal/jmm/10.1099/jmm.0.057877-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error